ADIPOQ and hepatocellular carcinoma: In this regard, a meta-analysis of 107 studies involving 19,319 cases of various malignancies and 25,675 controls demonstrated that a lower level of circulating adiponectin is associated with most types of cancer, but not HCC, in which the circulating adiponectin seems to be increased [70].